The CCl4-induced hepatic fibrosis model is commonly used for antifibrotic research, with many studies showing that CCl4, a hepatotoxic agent, activated the TGF-β1/Smad-signaling pathway and led to an accumulation of ECM [23,30]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.